SARSIA INNOVATION AS

Portfolio companies

 

Blue Limit AS
Blue Limit has developed a unique feed concept particularly well suited for the early development phases of fish and shellfish larvae. The feed is unique in that it may potentially replace today’s live feed. The company is a commercialisation of research carried out by Fiskeriforskning in Bergen.

EnSo AS
EnSo has developed a technology that uses electricity to neutralise unwanted marine organisms in ballast water. Tests have shown that the equipment has the potential to become one of the world’s first systems to meet stringent international limitations on remnants of bio-active substances left behind in ports. EnSo collaborates with Protech AS and Christian Michelsen Research as well as with a Norwegian shipping company in development of a prototype. The prototype will be tested by NIVA in order to achieve type approval by Det Norske Veritas.

 

Epsis AS
Epsis develops and delivers products and solutions for Integrated Operations to the oil and gas industry. Integrated Operations concerns optimisation of oil and gas production through real time data delivery and analysis.
www.epsis.no

 

NorDiag ASA
Molecular diagnostics in the fields of cancer and infectious diseases. NorDiag is listed at the Oslo Stock Exchange with ticker NORD.
www.nordiag.no

 

Novel Diagnostics ASA
Holding company owning PlasmAcute AS: Immunodiagnostic technology that brings forward the earliest point at which infection can be confirmed, with applications in general diagnostics and blood screening.
 www.noveldiagnostics.com